Key result
Simultaneous aortic and coronary sinus perfusion proves safe without causing myocardial edema or lactate production.
Why the study?
Does simultaneous aortic and coronary sinus cardioplegic perfusion provide safe myocardial protection in high-risk patients undergoing cardiac surgery?
Observational (n=174)
Yes
Does simultaneous aortic and coronary sinus cardioplegic perfusion provide safe myocardial protection in high-risk patients undergoing cardiac surgery?
Simultaneous antegrade and retrograde cardioplegic perfusion appears safe and prevents myocardial edema and lactate production in experimental models and high-risk clinical cardiac surgery.
Answers are grounded in this paper and cite their sources.
Should not yet change myocardial protection practice; leaves open randomized confirmation of simultaneous perfusion.
UNLABELLED: The existence of inhomogeneous distribution of coronary flow with antegrade or retrograde perfusion alone has led to alternating between these delivery routes to maximize their individual benefits. Concern over myocardial damage prevented the simultaneous application of antegrade and retrograde cardioplegic blood delivery. Based upon the predominance of retrograde drainage via Thebesian veins, and evidence that pressure-controlled intermittent coronary sinus occlusion during antegrade cardioplegic delivery enhances its distribution and protective properties, this study tests (a) the hypothesis that simultaneous aortic and coronary sinus perfusion is safe during aortic clamping, and (b) reports initial clinical application of this combined strategy in 174 patients. Five minipigs (25-30 kg) underwent 1 hr of aortic clamping with simultaneous aortic (antegrade) and coronary sinus (retrograde) perfusion at 200 ml/min with normal blood (37 degrees C) before and after 30 minutes of perfusion with either warm (37 degrees C) or cold (4 degrees C) blood cardioplegia (BCP). Furthermore, the combined strategy was used in 174 high-risk patients (NYHA class III-IV) at 3 university hospitals to perform myocardial protection during CABG or valve replacement, or a combination of both. Included were 16 patients in cardiogenic shock and 24 undergoing reoperation. In both the clinical and the experimental studies the coronary sinus pressure was always < 40 mmHg in beating or arrested hearts. EXPERIMENTAL: Compared to control values (81.4 +/- 0.4% tissue water content), no right-ventricular (80.8 +/- 0.8%) or left-ventricular (79.5 +/- 0.3%) edema developed, no lactate was produced (control: -1.0 +/- 0.5 mg/100 g/min, empty beating: -0.64 +/- 5, and BCP arrest: -8.6 +/- 6.6).(ABSTRACT TRUNCATED AT 250 WORDS)
No takes yet. Share an insight, caveat, or question.
Ihnken et al. (1994) conducted an observational in High-risk patients (NYHA class III-IV) undergoing CABG or valve replacement (n=174). Simultaneous aortic and coronary sinus perfusion was evaluated on Myocardial edema and lactate production (experimental). Simultaneous aortic and coronary sinus perfusion was safely applied in 174 high-risk patients, with experimental data showing no myocardial edema or lactate production.
Synapse has enriched 10 related papers. Consider them for comparative context: